Pharmatek Expands Packaging Services
News Oct 17, 2013
Pharmatek has announced the installation and qualification of an automated bottling line at its cGMP facility in San Diego, CA.
The addition of the line is part of the Company’s ongoing investment to support the increasing customer demand for larger scale productions. The line will be fully operational in November 2013.
The bottling line provides maximum flexibility and is beneficial for both small and large volume clinical packaging projects.
Manufactured by CVC Technologies, the line includes a Cremer electronic channel counter, capper, induction sealer, re-torquer and high speed wrap labeler. The system is integrated with a CVC electronic conveyor system and redundant quality inspection stations.
Automatic bottling improves the efficiency and accuracy of clinical packaging, resulting in a reduction in overall costs and time-to-clinic.
Additionally, the new bottling line significantly increases Pharmatek’s overall capacity, allowing higher throughput and larger GMP manufacturing runs.
“Our investment in automated clinical packaging illustrates our commitment to our customers’ need for strategies that streamline supply chain management and speed supplies to the clinic,” said Pharmatek president Tim Scott. “This is an important enhancement to our offering, enabling us to continue to support our customers throughout their development program and into larger scale operations.”
Pharmatek offers primary packaging of tablets and capsules in HDPE bottles. The Company supports secondary packaging, cold chain management, including storage and distribution, and stability testing.
Complex labeling requirements, such as foreign language labels, blinding and booklet- labeling, are also accommodated.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018